New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S2665

Introduced
2/12/24  

Caption

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

Impact

The proposed master plan is expected to have far-reaching effects on current state laws and regulations surrounding healthcare for Alzheimer's patients. It outlines several key objectives, such as improving healthcare quality, ensuring sustainable funding, fostering community engagement, and providing support to unpaid family caregivers. By setting these standards, the commission aims to create policies that align state resources more effectively with the specific needs of Alzheimer's patients, potentially transforming how care is delivered across New Jersey.

Summary

S2665 establishes the New Jersey Alzheimer's Disease Master Plan Study Commission within the Department of Human Services. This commission is tasked with developing a comprehensive master plan aimed at addressing the needs of individuals diagnosed with Alzheimer's and other related dementias. The commission will consist of 15 members, including state officials and appointees with expertise in healthcare, caregiving, and legal matters related to elder care. The intent is to prepare and guide the state on enhancing the quality of life for these individuals and their caregivers.

Contention

While the bill aims to positively impact the lives of individuals with Alzheimer's disease and their families, it may face contention regarding funding allocation and the scope of its proposed measures. Stakeholders may debate the adequacy of resources dedicated to executing the master plan and whether additional legislative action may be needed to ensure its success. There may also be concerns about the commission's authority to create and implement programs, as well as the potential unintended consequences of centralizing decision-making regarding elder care.

Companion Bills

NJ S1242

Carry Over Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A2924

Carry Over Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A6160

Same As Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

Previously Filed As

NJ S1243

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A1557

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ S2784

Establishes New Jersey-India Commission.

NJ S458

Establishes New Jersey Forensic Science Planning Commission.

NJ A972

Establishes New Jersey Forensic Science Planning Commission.

NJ A4930

Establishes "Kidney Disease Study Commission."

NJ A2631

Establishes "Long-Term Care Facility Infectious Disease Preparedness and Home Health Care Study Commission."

NJ S4237

Establishes "Kidney Disease Study Commission."

NJ S2751

Establishes New Jersey Commission on Health Equity.

NJ AJR161

Establishes New Jersey Pancreatic Cancer Commission.

Similar Bills

NJ S1243

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ A1557

Establishes "New Jersey Alzheimer's Disease Master Plan Study Commission."

NJ S1250

Requires DHS to establish Alzheimer's disease public awareness campaign.

WV HB4474

Extending the Alzheimer’s Disease and Other Dementia Advisory Council sunset date.

WV SB604

Extending Alzheimer's Disease and Other Dementia Advisory Council sunset date

HI SCR203

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.

HI HR30

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.

HI SR163

Requesting The University Of Hawaii To Explore The Feasibility Of Establishing An Alzheimer's Disease Research Center And Identify The Requirements For Receiving Federal Funding From The National Institute On Aging For Alzheimer's Disease Research.